Mankind Pharma’s consumer business division has introduced Nimulid Strong, a gel and spray formulation to address neck pain, a condition that impacts overall body function. With this launch, Mankind Pharma has entered the topical analgesic market.
To be available in gel and spray variants Nimulid Strong will be distributed across pharmacies and modern trade outlets nationwide. Nimulid Strong contains 2X diclofenac concentration, promising fast neck pain relief. The topical analgesic market in India is valued at ₹1,488 crores, according to IQVIA, states a Mankind Pharma press release. The product launch, while expanding its consumer healthcare portfolio, accompanies a video campaign in Hindi-language titled #GardanHilaateRaho that highlights the cultural significance of neck movements in Indian communication.
The campaign focuses on the importance of unrestricted neck movement with the efficacy of Nimulid Strong in alleviating neck pain. The tag line of Nimulid Strong campaign is “Kaam Chalate Raho, Gardan Hilaate Raho.” The video narrative connects various scenarios where neck movements play a crucial role in non-verbal communication, from expressing anger and love to showcasing progress and even celebrating national victories. It stresses how Nimulid Strong, with its 2X diclofenac formulation, ensures that neck pain doesn’t hinder these essential interactions.
The campaign video can be accessed from here: https://youtu.be/iRUQJL18hpg
Joy Chatterjee, Vice President, Sales and Marketing Head, Consumer Business Unit, Mankind Pharma, said, “Nimulid Strong marks a pivotal moment for Mankind Pharma’s consumer business. By focusing on neck pain, we aim to empower millions of Indians to live and communicate freely. Our 2X diclofenac formulation, paired with a resonant video campaign, showcases how integral neck movements are in daily interactions.”
